Subtype
Malignant Colorectal Neoplasm
CI-CAN-00005874Explore in graph →
1,565 active trials21 approved drugs382 evidence items
- NCIt
- C4978
- DOID
- 9256
- Other
- 1 more code
Loading cancer entity…
Subtype
CI-CAN-00005874Explore in graph →
Clinical trials
7,296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (722)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05156307 | Accuracy and Predictive Values for Colorectal Cancer of Quantitative FIT in Symptomatic Patients in Primary Care | unknown | — | 2,500 | Region Örebro CountyOTHER | 1 | Dec 14, 2021 | clinicaltrials |
| NCT03597126 | Short Term Outcomes of Robotic-assisted Intersphincteric Resection for Low Rectal Cancer(R-ISR) | unknown | N/A | 100 | Southwest Hospital, ChinaOTHER | 1 | Dec 9, 2021 |
| clinicaltrials |
| NCT05130021 | A Clincal Study of Max-40279-01 in Patients With Advanced Colorectal Cancer | unknown | Phase 2 | 130 | Maxinovel Pty., Ltd.INDUSTRY | 1 | Dec 6, 2021 | clinicaltrials |
| NCT04078828 | PR in Endoscopic LAR for Rectal Cancer | unknown | N/A | 10 | Southwest Hospital, ChinaOTHER | 1 | Nov 30, 2021 | clinicaltrials |
| NCT05131243 | the Role of ctDNA in Predicting the Recurrence Risk of Colorectal Cancer | unknown | N/A | 100 | Fujian Cancer HospitalOTHER_GOV | 0 | Nov 23, 2021 | clinicaltrials |
| NCT05131763 | NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors | unknown | Phase 1 | 3 | Fudan UniversityOTHER | 1 | Nov 23, 2021 | clinicaltrials |
| NCT05125393 | Evaluation the Safety of Indocyanine Green Guided Treatment of Henle Trunk(SIGHELC) | unknown | N/A | 128 | Shanghai East HospitalOTHER | 0 | Nov 18, 2021 | clinicaltrials |
| NCT04070898 | Prospective, Controlled, Randomized Multicentric Study on the Management of the Vesical Catheter in Colon Surgery. | unknown | N/A | 416 | Corporacion Parc TauliOTHER | 1 | Nov 16, 2021 | clinicaltrials |
| NCT04456933 | Intracorporeal Anastomosis in Laparoscopic Left Colectomy. Cohort Comparative Study(RIAL-COLECTOMY) | unknown | — | 148 | Corporacion Parc TauliOTHER | 1 | Nov 16, 2021 | clinicaltrials |
| NCT04764006 | Surufatinib Combined With Sintilimab for Advanced MSS-Type Colorectal Cancer : a Phase II Study | unknown | Phase 2 | 10 | Fujian Cancer HospitalOTHER_GOV | 1 | Nov 4, 2021 | clinicaltrials |
| NCT03218423 | Longitudinal Performance of Epi proColon(PERT) | unknown | — | 4,500 | Epigenomics, IncINDUSTRY | 1 | Nov 1, 2021 | clinicaltrials |
| NCT04065984 | Body Composition Manipulation in CoLorectal cancEr (BiCyCLE): Neuromuscular Electrical Stimulation (NMES)(BiCyCLE-NMES) | unknown | N/A | 46 | London North West Healthcare NHS TrustOTHER | 1 | Oct 29, 2021 | clinicaltrials |
| NCT04582981 | Fruquintinib and Raltitrexed Versus Fruquintinib Monotherapy in Advanced Colorectal Cancer | unknown | Phase 2 | 136 | Fudan UniversityOTHER | 1 | Oct 26, 2021 | clinicaltrials |
| NCT05077839 | Trifluridine/Tipiracil Combined With Oxaliplatin and Bevacizumab Versus XELOX Plus Bevacizumab in mCRC(TOBACO) | unknown | Phase 2 | 184 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Oct 25, 2021 | clinicaltrials |
| NCT05086601 | A Cohort of Molecular Characteristics and Prognosis of Colorectal Cancer | unknown | — | 15,000 | Fudan UniversityOTHER | 1 | Oct 21, 2021 | clinicaltrials |
| NCT04948762 | A Contemporary Review of Surgical Approaches in Pelvic Exenterative Surgery | unknown | — | 1,000 | St Vincent's University Hospital, IrelandOTHER | 1 | Oct 20, 2021 | clinicaltrials |
| NCT05068206 | A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeOx | unknown | Phase 2 | 120 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Oct 20, 2021 | clinicaltrials |
| NCT03146338 | Prophylaxis of Magnesium-rich Mineral Water to Prevent Hypomagnesemia Induced by an Anti-EGFR (OPTIMAG)(OPTIMAG) | unknown | N/A | 106 | WepromOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT05079438 | Dendrobium Huoshanense Suppository in Rectal Cancer | unknown | Phase 3 | 168 | Zhejiang Cancer HospitalOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT05079503 | Gut Microbiome and Its Immune Modulation in Locally Advanced Rectal Cancer | unknown | N/A | 40 | Korean Cancer Study GroupOTHER | 0 | Oct 15, 2021 | clinicaltrials |
| NCT05077358 | Intracorporeal Versus Extracorporeal Anastomosis In Laparoscopic Right Colon Resection | unknown | N/A | 241 | Yonsei UniversityOTHER | 1 | Oct 14, 2021 | clinicaltrials |
| NCT05076305 | PelvEx 4: Advanced Pelvic Malignancy and the Role of the Multi-disciplinary Team Meeting | unknown | — | 12 | St Vincent's University Hospital, IrelandOTHER | 1 | Oct 13, 2021 | clinicaltrials |
| NCT01688232 | The Immunoscore as a Prognostic Marker for Patients With a Colorectal Cancer(IMMUCOL) | unknown | — | 459 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Oct 12, 2021 | clinicaltrials |
| NCT02274753 | Personalizing Colorectal Cancer Medicine (ImmuCol2)(ImmuCol2) | unknown | — | 220 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Oct 12, 2021 | clinicaltrials |
| NCT04774757 | Systemic Therapy Sequenced Isolated PALND for mCRC | unknown | N/A | 39 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Oct 11, 2021 | clinicaltrials |
| NCT04037319 | Atrial Fibrillation After Surgery for Colorectal Cancer(AFAR) | unknown | — | 720 | Sheffield Teaching Hospitals NHS Foundation TrustOTHER | 1 | Oct 8, 2021 | clinicaltrials |
| NCT02826837 | LEAC-102 for Advanced Colorectal Cancer | unknown | Phase 1 / Phase 2 | 30 | Taiwan Leader Biotech Corp.INDUSTRY | 0 | Oct 6, 2021 | clinicaltrials |
| NCT05051592 | Role of Circulating Tumour DNA Testing in Assessing for Alterations of Primary Anti-EGFR Resistance in RAS/RAF Wild-type Metastatic Colorectal Cancer Patients | unknown | — | 40 | National University Hospital, SingaporeOTHER | 1 | Oct 5, 2021 | clinicaltrials |
| NCT01899547 | Laparoscopy-Assisted Surgery for Carcinoma of the Low Rectum(LASRE) | unknown | N/A | 1,070 | Fujian Medical UniversityOTHER | 1 | Oct 1, 2021 | clinicaltrials |
| NCT05028192 | Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia(MEx) | unknown | — | 144 | University of Turin, ItalyOTHER | 1 | Sep 29, 2021 | clinicaltrials |
| NCT04781270 | mFOLFOXIRI+Bev vs. mFOLFOX6+Bev for RAS Mutant Unresectable Colorectal Liver-limited Metastases | unknown | Phase 3 | 308 | Fudan UniversityOTHER | 1 | Sep 27, 2021 | clinicaltrials |
| NCT04069455 | ePRO for Adjuvant Therapy of Colorectal Adenocarcinoma | unknown | N/A | 270 | Zhejiang UniversityOTHER | 1 | Sep 17, 2021 | clinicaltrials |
| NCT02948348 | Study to Nivolumab Following Preoperative Chemoradiotherapy | unknown | Phase 1 / Phase 2 | 90 | Takayuki YoshinoOTHER | 1 | Sep 16, 2021 | clinicaltrials |
| NCT05046756 | Postoperative Prognosis Management Service Based mHealth for Colon Cancer Patients | unknown | N/A | 324 | Korea University Anam HospitalOTHER | 1 | Sep 16, 2021 | clinicaltrials |
| NCT04434963 | Safety and Feasibility of Reversible Induction Strategy | unknown | — | 20 | RenJi HospitalOTHER | 1 | Sep 14, 2021 | clinicaltrials |
| NCT02406118 | Phase II Clinical Trial for the Evaluation of the Efficacy of Transanal TME | unknown | N/A | 49 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 10, 2021 | clinicaltrials |
| NCT02421432 | Evaluation of the Safety and the Efficacy of Transanal TME in Difficult Cases | unknown | N/A | 12 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 10, 2021 | clinicaltrials |
| NCT05039060 | Modified MAC Diet and Gut Microbiota in CRC Patients | unknown | N/A | 40 | Korea University Anam HospitalOTHER | 1 | Sep 9, 2021 | clinicaltrials |
| NCT04287400 | Prospective Trial for the Evaluation of Radiogenomics in Advanced Rectal Cancer | unknown | — | 210 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 5, 2021 | clinicaltrials |
| NCT05035914 | Anlotinib Combined With mXELIRI as Second-line Treatment of Advanced Colorectal Cancer | unknown | Phase 1 / Phase 2 | 94 | Guangzhou University of Traditional Chinese MedicineOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT04890015 | The Impact of Transanal Decompression Tube Placement After Colorectal Anastomosis: A Randomized Trial(SONDES) | unknown | N/A | 202 | Institut d'Investigació Biomèdica de Girona Dr. Josep TruetaOTHER | 1 | Sep 2, 2021 | clinicaltrials |
| NCT04905147 | Efficacy of Mosapride on Recovery of Intestinal Motility After Elective Colorectal Cancer Surgery | unknown | N/A | 44 | Mahidol UniversityOTHER | 1 | Sep 2, 2021 | clinicaltrials |
| NCT03126071 | Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer | unknown | Phase 2 | 100 | Jiangsu Cancer Institute & HospitalOTHER | 1 | Aug 30, 2021 | clinicaltrials |
| NCT04241731 | A Study of Cetuximab Plus Raltitrexed for Maintenance Treatment in Advanced Colorectal Cancer | unknown | Phase 2 | 50 | Jiangsu Cancer Institute & HospitalOTHER | 1 | Aug 30, 2021 | clinicaltrials |
| NCT04324476 | A Study of Bevacizumab Plus XELOX/XELIRI for First-line Treatment in Unresectable Advanced Colorectal Cancer | unknown | Phase 2 | 50 | Jiangsu Cancer Institute & HospitalOTHER | 1 | Aug 30, 2021 | clinicaltrials |
| NCT05026268 | The Laparoscopic Right Colectomy With Intracoroporeal Anastomosis(LaRCIa) | unknown | N/A | 2 | State Scientific Centre of Coloproctology, Russian FederationOTHER_GOV | 1 | Aug 30, 2021 | clinicaltrials |
| NCT04948034 | The Combination of Fruquintinib, Tislelizumab and Stereotactic Ablative Radiotherapy in Metastatic Colorectal Cancer(RIFLE) | unknown | Phase 2 | 68 | Fudan UniversityOTHER | 1 | Aug 27, 2021 | clinicaltrials |
| NCT05020613 | Early and Late Removal of the Urinary Catheter After Rectum Resection | unknown | N/A | 120 | Marmara UniversityOTHER | 1 | Aug 25, 2021 | clinicaltrials |
| NCT04466254 | Efficacy and Safety Study of Combination of CPGJ602 and Chemotherapy, in First Line, With Wild KRAS/NRAS/BRAF in Metastatic Colorectal Cancer | unknown | Phase 2 | 75 | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.INDUSTRY | 1 | Aug 23, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Dec 14, 2021source: clinicaltrials